KAHR Medical kahr-medical.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

KAHR Medical is an Israeli biotech company developing a drug platform known as DSP (Dual Signaling Proteins), bi-functional fusion proteins that are based on the TNF-superfamily, the proteins that control the immune system. KAHR's technology allows the construction of biological drugs with two functional sides that allow these drugs to block or activate two reinforcing biological signals at the same time. KAHR's DSP platforms, named DSP-Hexamers and DSP-Clusters, form a new generation of biologi...Show all

KAHR Medical is an Israeli biotech company developing a drug platform known as DSP (Dual Signaling Proteins), bi-functional fusion proteins that are based on the TNF-superfamily, the proteins that control the immune system. KAHR's technology allows t...Show all

Company (Alive / Active)

All investors data 9 Investors

Phone: +972 737969196

Fax:

1 Kiryat Hadassah JPG Bdlg.

 Jerusalem, 9109701
 Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
KAHR Medical $38.9M Feb 25, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related KAHR Medical Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors

Board Members

Name Firm
Login to see detailsToronto Innovation Acceleration Partners
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Stable form of signal converting protein fusion proteins, and methods of use and preparation thereof Dec 31, 2013 Aug 07, 2018 Patent
Compositions and methods for treatment of hematological malignancies Jun 09, 2016 Jun 19, 2018 Patent
Compositions and methods for treatment of hematological malignancies Sep 28, 2011 Jul 12, 2016 Patent
Stable form of signal converting protein fusion proteins, and methods of use and preparation thereof Jul 05, 2018 Application
Sirpalpha-41bbl fusion protein and methods of use thereof Jan 04, 2018 Application
See all 8 patents